Lv21
128 积分 2022-07-22 加入
Lineage identity governs oncogene dependence in mouse NSCLC models of KRAS inhibitor resistance
7小时前
已完结
Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer
19天前
已完结
Adaptive Feedback Signaling Through the FAK/SRC Pathway Promotes KRAS G12C Inhibitor Resistance
23天前
已完结
YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial
1个月前
已完结
KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming
1个月前
已完结
Passenger mutations link cellular origin and transcriptional identity in human lung adenocarcinomas
1个月前
已完结
Response and Resistance to RAS Inhibition in Cancer
1个月前
已完结
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
1个月前
已完结
Fulzerasib plus cetuximab in first-line KRASG12C-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
1个月前
已完结
The discovery of oncogene-induced senescence
1个月前
已完结
皖公网安备34019202002308
